Trade 3SBio Inc. - 1530 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.022078% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00016% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 10 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.45 |
| Open | 6.75 |
| 1-Year Change | 28.57% |
| Day's Range | 6.6 - 6.9 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 6.75 | 0.20 | 3.05% | 6.55 | 6.90 | 6.55 |
| Feb 20, 2025 | 6.45 | -0.20 | -3.01% | 6.65 | 6.75 | 6.45 |
| Feb 19, 2025 | 6.65 | 0.25 | 3.91% | 6.40 | 6.70 | 6.40 |
| Feb 18, 2025 | 6.50 | 0.05 | 0.78% | 6.45 | 6.55 | 6.35 |
| Feb 17, 2025 | 6.40 | -0.30 | -4.48% | 6.70 | 6.75 | 6.35 |
| Feb 14, 2025 | 6.65 | 0.25 | 3.91% | 6.40 | 6.70 | 6.40 |
| Feb 13, 2025 | 6.35 | 0.00 | 0.00% | 6.35 | 6.50 | 6.30 |
| Feb 12, 2025 | 6.30 | 0.05 | 0.80% | 6.25 | 6.35 | 6.20 |
| Feb 11, 2025 | 6.25 | -0.15 | -2.34% | 6.40 | 6.40 | 6.25 |
| Feb 10, 2025 | 6.45 | 0.15 | 2.38% | 6.30 | 6.50 | 6.30 |
| Feb 7, 2025 | 6.40 | 0.05 | 0.79% | 6.35 | 6.55 | 6.30 |
| Feb 6, 2025 | 6.35 | 0.25 | 4.10% | 6.10 | 6.35 | 6.10 |
| Feb 5, 2025 | 6.10 | 0.00 | 0.00% | 6.10 | 6.20 | 6.05 |
| Feb 4, 2025 | 6.05 | -0.05 | -0.82% | 6.10 | 6.15 | 6.00 |
| Feb 3, 2025 | 6.05 | 0.10 | 1.68% | 5.95 | 6.15 | 5.75 |
| Jan 28, 2025 | 6.00 | -0.15 | -2.44% | 6.15 | 6.15 | 5.95 |
| Jan 27, 2025 | 6.15 | 0.05 | 0.82% | 6.10 | 6.15 | 6.05 |
| Jan 24, 2025 | 6.10 | -0.05 | -0.81% | 6.15 | 6.20 | 6.05 |
| Jan 23, 2025 | 6.15 | -0.15 | -2.38% | 6.30 | 6.40 | 6.15 |
| Jan 22, 2025 | 6.30 | 0.05 | 0.80% | 6.25 | 6.35 | 6.20 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
3SBio Company profile
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.| Industry: | Biopharmaceuticals |
瀋陽經濟技術開發區十號路1甲3號
SHENYANG
LIAONING
CN
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com